Hardening of the Arteries in the Brain and Life Expectancy

Hardening of the arteries in the brain, known medically as intracranial atherosclerosis, does shorten life expectancy, though how much depends on the severity of the disease, whether it has already caused a stroke, and what other vascular problems exist alongside it. In one long-term follow-up of patients with significant narrowing of an intracranial artery, the observed five-year survival rate was 60%, compared with an expected 87% for the general population of the same age. That gap is striking, but it reflects a population already sick enough to be diagnosed. For many people, intracranial artery calcification is a silent finding on a brain scan, and the relationship between those calcium deposits and how long you live is more complicated than a single number can capture.

What “Hardening of the Arteries in the Brain” Actually Means

The phrase covers two related but distinct problems. The first is atherosclerosis of the large and medium-sized arteries inside the skull, particularly the internal carotid arteries, the middle cerebral arteries, and the vertebrobasilar system. Fatty plaques build up in the vessel walls, calcify over time, and can narrow the channel through which blood flows. The second is disease of the brain’s tiny blood vessels, often called cerebral small vessel disease. Small vessel disease stiffens and thickens the walls of arterioles deep in the brain, reducing blood flow to the white matter and deep gray structures. These two forms of vascular disease frequently coexist, but they carry somewhat different risks. Large-artery intracranial atherosclerosis tends to increase the chance of stroke, while small vessel disease is more closely tied to gradual cognitive decline, disability, and a higher rate of brain bleeds.

How Common Is It

Remarkably common. A large population-based study found that some degree of intracranial carotid artery calcification was present in over 82% of participants, with age being the strongest predictor of its presence and volume in both men and women.¹ That number sounds alarming until you consider that most of those people had small amounts of calcification and no symptoms. The condition becomes almost universal in advanced age. An autopsy-based review noted that brain arteriolosclerosis, the small-vessel form of the disease, is found in more than 80% of people examined after death who were over 80 years old.² Certain populations face even higher rates earlier in life. Among hemodialysis patients, for example, intracranial calcifications were found in roughly 88%, compared with about 54% in age-matched controls.³

The takeaway is that having some calcium in your brain arteries does not, by itself, mean your life is in immediate danger. What matters is how much, where exactly it is, and whether it is actively narrowing blood flow or destabilizing plaques that could trigger a stroke.

What the Mortality Data Show

The clearest survival figures come from studies of people who already have symptomatic disease. In a classic follow-up of 66 patients with at least 50% narrowing of an intracranial internal carotid artery, half died during an average follow-up of just under four years. Over half of those deaths were from heart disease rather than stroke, underscoring that intracranial atherosclerosis rarely exists in isolation. The five-year survival rate of 60% fell far short of the 87% expected for a healthy same-age population.⁴ A study of Chinese stroke patients with predominant intracranial atherosclerosis found a cumulative mortality rate of about 21% over three and a half years. Patients who had both intracranial and extracranial artery disease faced the highest risk of death and further vascular events.⁵

For people whose intracranial disease has not caused a stroke, the picture is less dire but still concerning. Among ischemic stroke survivors, those with the highest calcification scores in their intracranial arteries had significantly higher rates of death and vascular events after hospital discharge compared to those with the lowest scores.⁶ The Rotterdam Study, a large population-based project, found that larger calcification volumes in all major vessel beds, including the intracranial arteries, were tied to higher all-cause mortality, cardiovascular mortality, and even non-cardiovascular mortality, independent of traditional risk factors like blood pressure and cholesterol.⁷

Small vessel disease also carries a mortality signal, though it is less straightforward. In a cohort of older patients, those with cerebral small vessel disease had roughly 60% higher odds of dying over a median follow-up of about three years compared to those without it, even after adjusting for heart disease, blood pressure, physical function, and cognitive status.⁸ However, the relationship is not perfectly linear. One study of middle-aged to older adults found that small vessel disease scores did not predict mortality in a clean dose-dependent fashion, suggesting other factors muddy the waters.⁹

When the Narrowing Has Not Caused Symptoms

Many people discover they have intracranial artery narrowing incidentally, during imaging for something unrelated. If the narrowed artery has never caused a stroke or transient ischemic attack in its own territory, the prognosis is considerably better than the numbers above suggest. A study following over 150 patients with asymptomatic intracranial stenosis after a minor stroke or TIA found that the seven-year risk of a stroke in the territory of that narrowed artery was under 7%, with an annualized risk below 1%. Their overall risk of death and vascular events was not significantly different from patients without intracranial stenosis.¹⁰ This is an important distinction. An incidental finding of narrowing that has never caused trouble is a very different beast from an artery that has already thrown off a clot or starved brain tissue of oxygen.

How Brain Artery Disease Leads to Harm

The damage is not just about blockages. Stiffened, calcified arteries lose their ability to regulate blood flow in response to the brain’s changing demands. Your brain normally adjusts its own blood supply second by second, sending more blood to regions that are working harder. This process, called cerebral autoregulation, breaks down when the arteries feeding the brain become rigid. Animal research has shown that calcification of the carotid arteries directly impairs the brain’s blood flow responses, both at baseline and during neuronal activity.¹¹ Accumulating evidence in humans ties increased central arterial stiffness to impaired cerebral blood flow regulation and accelerated brain aging.¹²

This chronic low-grade mismatch between what the brain needs and what the arteries can deliver likely explains why intracranial atherosclerosis does not just cause strokes. It also contributes to the slow erosion of brain tissue, white matter damage, and the quiet accumulation of tiny infarcts that feed into cognitive decline and frailty over years.

The Link to Dementia and Cognitive Decline

One of the most consequential effects of brain artery disease on quality of life, beyond strokes, is its role in dementia. Atherosclerosis is closely tied to vascular dementia, the second most common form of dementia after Alzheimer’s disease.¹³ But the relationship goes further. A population-based cohort followed for over 13 years found that both the presence and volume of intracranial carotid artery calcification increased the risk of developing dementia, with a roughly 50% higher risk among those with calcification present. Severe calcification of the vertebrobasilar arteries nearly doubled the risk. Part of this effect was mediated through the development of cerebral small vessel disease, meaning the large-artery disease was contributing to small-vessel damage downstream.¹⁴

Even without full-blown dementia, brain arteriolosclerosis chips away at cognitive function. A study examining people who died without severe dementia found that the small-vessel disease in their brains was independently associated with lower scores in memory, executive function, and language, even after controlling for Alzheimer’s pathology.¹⁵ Autopsy studies also link brain arteriolosclerosis to impairments in working memory and processing speed, as well as motor symptoms and autonomic dysfunction.¹⁶ The practical implication is that protecting your brain arteries is not just about preventing a catastrophic stroke. It is also about preserving the cognitive sharpness and physical independence that define a good later life.

Risk Factors That Drive the Disease

The usual cardiovascular suspects are the main drivers. High blood pressure stands at the top of the list, and its effects on the brain’s blood vessels may be permanent even if blood pressure is later brought under control. Animal research has shown that even a temporary period of elevated blood pressure causes lasting damage to the brain’s small vessels and surrounding tissue, with the worst outcomes seen when hypertension exists alongside Alzheimer’s pathology.¹⁷ Diabetes, high cholesterol, smoking, atrial fibrillation, and previous strokes all increase both the severity of intracranial atherosclerosis and the risk of poor outcomes. A multi-variable analysis found that the number of abnormal arteries, advancing age, diabetes, atrial fibrillation, and a history of prior stroke were all significant predictors of death or further vascular events.¹⁸

Kidney disease deserves special mention. Hemodialysis patients show dramatically higher rates of intracranial calcification than the general population, with nearly 88% affected compared to roughly 54% of controls.¹⁹ The disordered calcium and phosphorus metabolism that accompanies kidney failure accelerates calcification throughout the body, and the brain’s arteries are no exception.

Genetics also play a role. Variants in genes related to fat metabolism, blood vessel inflammation, and the renin-angiotensin system have been linked to intracranial atherosclerosis, including genes involved in adiponectin signaling, apolipoprotein E function, and blood vessel remodeling.²⁰ This partly explains why some people with well-controlled risk factors still develop significant brain artery disease, and why certain ethnic groups are disproportionately affected.

Differences Between Men and Women

Intracranial atherosclerosis shows up about as often in women as in men when you look at stroke patients overall. One study found intracranial atherosclerosis in 71% of women and 72% of men with acute ischemic stroke, with no significant difference in calcification volume between sexes in either the carotid or vertebrobasilar arteries.²¹ However, when hypertension is in the picture, men carry a heavier plaque burden. Among stroke patients with high blood pressure, men had about 60% more total plaques and 40% more plaques in the proximal intracranial arteries than women. Interestingly, women on blood pressure medication showed a greater reduction in proximal plaque burden than men, suggesting that hypertension treatment may be particularly protective for women’s brain arteries.²²

Treatment and What Can Be Done

There is no procedure to scrub calcium out of brain arteries. Unlike heart disease, where stenting and bypass surgery are well-established, the brain’s arteries are harder to reach and more dangerous to intervene on surgically. Trials of intracranial stenting for atherosclerotic narrowing have generally shown high complication rates, and for most patients, medical therapy is the standard approach.

That medical therapy has been getting better. The INSPIRES trial, a large randomized study, tested whether combining two blood-thinning drugs and intensive statin therapy could reduce recurrent strokes in people whose original stroke was caused by atherosclerosis of the brain or neck arteries. The dual antiplatelet arm saw a recurrent stroke rate of about 7.3% at 90 days, compared with about 9.2% for aspirin alone.²³ That improvement may look modest in percentage points, but it represents a meaningful reduction in the risk of a second stroke during the highest-risk window after the first one.

Beyond medications, aerobic exercise has shown measurable benefits for the brain’s blood supply. A year-long exercise training program in people with mild cognitive impairment reduced carotid artery stiffness and increased cerebral blood flow. Improvements in fitness were directly correlated with improvements in brain perfusion: the fitter people got, the more blood reached their brains.²⁴ This does not reverse calcification that has already formed, but it appears to improve the functional consequences of stiff arteries by helping the vascular system compensate.

Blood pressure control remains the single most impactful modifiable factor. Given the evidence that even temporary periods of high blood pressure can cause lasting cerebrovascular damage, the case for early and sustained treatment is strong. Managing diabetes, quitting smoking, and treating high cholesterol all reduce the systemic atherosclerotic burden that drives the disease forward.

How It Gets Detected

Most people learn about intracranial atherosclerosis in one of two ways: either they have a stroke and imaging reveals the culprit artery, or calcium deposits show up incidentally on a CT scan done for another reason. Standard brain CT picks up calcification well, and it is visible as bright white spots along the course of the arteries. The location of the calcium matters. One imaging study found that calcifications in the inner layer of the artery wall were far more likely to coexist with atherosclerotic plaques than calcifications in the outer layer, and, somewhat counterintuitively, inner-layer calcification was associated with more stable, non-culprit plaques rather than the unstable ones that cause strokes.²⁵ This is reminiscent of what we see in heart arteries, where heavily calcified plaques are often less prone to rupture than softer, less calcified ones.

MRI-based vessel wall imaging and CT angiography give more detailed views of plaque composition and the degree of narrowing. When calcification is severe on CT, MRI tends to confirm a higher overall burden of vessel wall disease.²⁶ The challenge is that imaging tells you what the arteries look like at one point in time but cannot easily predict which plaques will cause problems next. Research into blood-based biomarkers, including markers of vascular inflammation and growth factor signaling, is trying to fill that gap by identifying people at highest risk of disease progression before the next stroke happens.²⁷

The Systemic Nature of the Problem

Perhaps the most important thing to understand about hardening of the brain’s arteries is that it is almost never just a brain problem. It is a window into what is happening throughout your vascular system. Arterial calcification involving the brain has been associated with small vessel disease, white matter damage, and cortical atrophy, but the same process is typically advancing in the coronary arteries, the aorta, and the arteries of the legs and kidneys. Recall that in the study of patients with significant intracranial narrowing, over half of all deaths were cardiac rather than neurological.²⁸ Your brain artery finding is, in many cases, a signal to evaluate and protect the whole cardiovascular system, not just the brain.

This systemic framing also helps explain why the mortality data are so variable. A person with isolated, mild intracranial calcification and no other vascular disease is in a fundamentally different situation from someone with severe, multi-vessel atherosclerosis and diabetes. The disease is the same pathology at different stages and in different contexts, and the life-expectancy implications vary accordingly. Broad population studies confirm that calcification volume across all vascular beds predicts mortality, but the risk is graded, not binary.²⁹ There is no single life-expectancy number that applies to everyone with intracranial atherosclerosis. What exists is a spectrum, shaped by how far the disease has progressed, what else is going on in the body, and how aggressively the modifiable risk factors are being managed.